In addition, shifts in the plasma amounts of CT-1 are connected to other forms of cardiomyopathies, such as ischemic cardiomyopathy, which reduces its specificity as a biomarker for DCM [107]. This evidence concerns the gene CTF1 and familial dilated cardiomyopathy.